Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.
about
Design and pre-clinical evaluation of a universal HIV-1 vaccineThe spread, treatment, and prevention of HIV-1: evolution of a global pandemicDemystified. Human endogenous retrovirusesHost background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individualsEvidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera.Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCVReduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central AfricansResistance to HIV InfectionHepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCVDynamics of the CD8 T-cell response following yellow fever virus 17D immunizationExpression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccinesIs there a role for plant-made vaccines in the prevention of HIV/AIDS?Current issues in the development of a vaccine to prevent human immunodeficiency virus: insights from the society of infectious diseases pharmacists.Amplified transmission of HIV-1: missing link in the HIV pandemicHIV-1 Vaccine Trials: Evolving Concepts and DesignsHuman immunodeficiency virus-specific CD8(+) T cells in human breast milk.The role of cytokines which signal through the common gamma chain cytokine receptor in the reversal of HIV specific CD4(+) and CD8(+) T cell anergyEstablishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study.Modelling HIV immune response and validation with clinical data.Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in AfricaEffective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimenInhibition of human immunodeficiency virus type 1 replication in primary CD4(+) T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes.The search for an HIV vaccineCD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted.Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates.Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA allelesInfluence of HLA class I haplotypes on HIV-1 seroconversion and disease progression in Pumwani sex worker cohort.Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine designMature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals.Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques.Induction of potent human immunodeficiency virus type 1-specific T-cell-restricted immunity by genetically modified dendritic cells.Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes.HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificitiesChallenges and opportunities for development of an AIDS vaccine.Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmissionDisparate associations of HLA class I markers with HIV-1 acquisition and control of viremia in an African population.
P2860
Q21092234-3FFA89CA-6B2B-48D8-A79E-D4360CB33CBBQ22241890-73F4B720-FEE2-4FF5-AEE9-0BCB15F5E031Q23067954-0C071971-102D-4AE0-99DA-1682368E3F5AQ24531918-C03B16D8-3F12-4CB1-A639-7D65C718BBA4Q24648051-7EA7A22B-DB67-4687-86B9-F3C19BFEF1F1Q24815966-453EE392-FC45-40FA-8CA9-E1663529B06CQ27469764-24098802-E04D-46AD-963A-5E318D9FB4F2Q27473420-9F76C73C-FFF5-4AE0-8291-17652B25EAABQ27473466-EEEDDD42-B0AA-48DA-948D-A9A55ECC01FCQ27488816-C279DFB1-DD8C-42AA-A4BE-5D5158C4343CQ27489813-F69F9A1C-5A3F-4E47-AC20-656CE5257747Q30332833-09921DA0-18E1-4827-9805-27AE53050CB8Q30350670-D8AC7343-634D-40A1-80CD-5A10B9BD37D7Q30350731-36672F91-906F-44A0-8474-9BC0C27814DCQ30369759-27C398D9-EDE9-4CCD-B42E-B6584CCD54C3Q30425520-A0E6891B-CDE1-4094-ADD6-049013A1C619Q31093697-773E9941-0EDD-47B1-9772-B641447171DBQ33279519-D01728DF-99E6-4204-A634-955010A3955EQ33328477-24EF91D3-FA2A-4044-B2C4-5580C5547C58Q33460449-045C135C-7CD4-4662-A030-264C34519826Q33602772-03D6F882-390A-47EF-B8AC-B6A856F7FDD8Q33642531-D3B07039-8FCD-49D3-BC76-5CA5D780DBACQ33649842-11F25AC0-D30E-4610-8614-A116FB35E4A5Q33808351-0AABB7F2-DBB5-4E60-A861-DC2FD247D450Q33808828-B3F6D03C-9D42-4820-854F-C544AD8AD4D6Q33835440-05D48C91-ECF3-460C-A7E8-CD5B7CA031B0Q33839136-C1B3A9EB-F7C2-4425-AEEB-ECE149708ABBQ33839981-C86C8E4B-0255-49C9-BE91-B84BA5AA55C3Q33842771-03439C08-9095-472C-8AEB-FC2E44F8EAC8Q33845015-F2EFF063-CB10-401C-99CA-66F9FF28CFEAQ33845527-2DBC3C8E-130E-46BE-8FEA-02F5751043F7Q33850510-4073DF24-8885-46AE-9FFA-592D09082DE9Q33851266-BD89F125-08F1-4F32-B2F3-A369AA9D214EQ33852947-C89C7486-7DA2-4494-A680-B33FEE3A6106Q33854564-4781F77E-B321-467F-956A-89D70E49B324Q33930290-C18CA895-42F8-406D-904B-F975F373B78AQ33939974-A78AD02C-D266-4D8D-8814-ED35D447749FQ33942996-E5A017F8-23B5-4F39-A72C-1052FAC6AE01Q33987424-B04B0788-F30B-4548-93CE-46EF7B2CF3D1Q33999689-7C2D21DB-E7E8-4D7F-89E7-88CBDF796542
P2860
Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Cytotoxic T cell responses to ...... istant prostitutes in Nairobi.
@en
Cytotoxic T cell responses to ...... istant prostitutes in Nairobi.
@nl
type
label
Cytotoxic T cell responses to ...... istant prostitutes in Nairobi.
@en
Cytotoxic T cell responses to ...... istant prostitutes in Nairobi.
@nl
prefLabel
Cytotoxic T cell responses to ...... istant prostitutes in Nairobi.
@en
Cytotoxic T cell responses to ...... istant prostitutes in Nairobi.
@nl
P2093
P2860
P356
P1476
Cytotoxic T cell responses to ...... istant prostitutes in Nairobi.
@en
P2093
A J McMichael
F A Plummer
K Ariyoshi
K S MacDonald
P2860
P304
P356
10.1172/JCI4314
P407
P577
1998-11-01T00:00:00Z